Carrier-free Arg-CpG augments antitumor efficacy by triggering specific immune activation

The delivery of nucleic acids using nonviral vectors represents a promising approach for cancer therapy. Nevertheless, nucleic acid-based drugs suffer from poor potency and rapid degradation. Herein, we report a carrier-free nucleic acid delivery system termed Arg-CpG, which is easily constructed through charge-driven assembly of poly(l-arginine) (Arg) and the immune adjuvant unmethylated cytosine-phosphate-guanine oligonucleotide (CpG). This Arg-CpG functions as both a carrier and a therapeutic agent, thereby eliminating the need for a conventional drug delivery vehicle and minimizing potential toxicity. The guanidinium groups of Arg endow Arg-CpG with dual functionalities: enhancing cellular uptake and serving as the nitrogen donor for iNOS-mediated nitric oxide (NO) generation. This NO production further synergizes with CpG to drive macrophage reprogramming toward an antitumor phenotype. Notably, Arg-CpG exhibits cell-type-dependent modulation of autophagy. It disrupts autophagic machinery in 4T1 tumor cells while preserving functional autophagy in RAW264.7 macrophages. This differential activity results in selective killing of tumor cells without compromising the viability or function of normal immune cells. Consequently, Arg-CpG elicits a robust antitumor immune response in vivo. Moreover, the modular design of Arg-CpG enables its straightforward assembly with CpG oligonucleotides and other nucleic acid payloads (e.g., anti-miR oligonucleotides and siRNA), establishing a versatile and promising platform for nucleic acid-based cancer therapy.

Authors

Institutions

Publication Details

Journal
Science Advances
Published
2026-11-13
DOI
https://doi.org/10.1126/sciadv.aeg8936
Primary Topic
RNA Interference and Gene Delivery
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Carrier-free Arg-CpG augments antitumor efficacy by triggering specific immune activation

Xue Zhao, Peifeng Liu, Yuexia Xie, Shuai Yang et al.
Science Advances
RNA Interference and Gene Delivery
article

Carrier-free Arg-CpG augments antitumor efficacy by triggering specific immune activation

Xue Zhao, Peifeng Liu, Yuexia Xie, Shuai Yang, Xiaozhen He, Fangli Cao, Yongming Han, Lu Gan, Quankun Lin, Huishan Li, Xingang Wang, Sidi Zhang, Yan Zhou
article en

Abstract

The delivery of nucleic acids using nonviral vectors represents a promising approach for cancer therapy. Nevertheless, nucleic acid-based drugs suffer from poor potency and rapid degradation. Herein, we report a carrier-free nucleic acid delivery system termed Arg-CpG, which is easily constructed through charge-driven assembly of poly(l-arginine) (Arg) and the immune adjuvant unmethylated cytosine-phosphate-guanine oligonucleotide (CpG). This Arg-CpG functions as both a carrier and a therapeutic agent, thereby eliminating the need for a conventional drug delivery vehicle and minimizing potential toxicity. The guanidinium groups of Arg endow Arg-CpG with dual functionalities: enhancing cellular uptake and serving as the nitrogen donor for iNOS-mediated nitric oxide (NO) generation. This NO production further synergizes with CpG to drive macrophage reprogramming toward an antitumor phenotype. Notably, Arg-CpG exhibits cell-type-dependent modulation of autophagy. It disrupts autophagic machinery in 4T1 tumor cells while preserving functional autophagy in RAW264.7 macrophages. This differential activity results in selective killing of tumor cells without compromising the viability or function of normal immune cells. Consequently, Arg-CpG elicits a robust antitumor immune response in vivo. Moreover, the modular design of Arg-CpG enables its straightforward assembly with CpG oligonucleotides and other nucleic acid payloads (e.g., anti-miR oligonucleotides and siRNA), establishing a versatile and promising platform for nucleic acid-based cancer therapy.

Science AdvancesVol. 12(46)
Zunyi Medical University (CN), Shanghai Jiao Tong University (CN), Fudan University (CN), Renji Hospital (CN), Jiading District Central Hospital (CN), Shanghai Cancer Institute (CN), Zhongshan Hospital (CN), Qilu Hospital of Shandong University (CN)
Natural Science Foundation of Shanghai, National Natural Science Foundation of China
Good health and well-being
RNA Interference and Gene Delivery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon